Erik Škof
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
-
- Colorectal Cancer Treatments and Studies
- PARP inhibition in cancer therapy
Papers in
-
- Ovarian cancer diagnosis and treatment 15
- Oncology 21
- PARP inhibition in cancer therapy 8
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 3
- Cancer Cells and Metastasis 3
Erik Škof
30 papers receiving 342 citations
Peers
Comparison fields: 5 of 55
- Reproductive Medicine 115
- Oncology 173
- Obstetrics and Gynecology 30
- Hepatology 28
- Cancer Research 44
Countries citing papers authored by Erik Škof
This map shows the geographic impact of Erik Škof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Škof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Škof more than expected).
Fields of papers citing papers by Erik Škof
This network shows the impact of papers produced by Erik Škof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Škof. The network helps show where Erik Škof may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Škof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 29 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 15 | |
| 14 | 2019 | 24 | |
| 15 | 2018 | 38 | |
| 16 | 2016 | 10 | |
| 17 | 2011 | 22 | |
| 18 | 2010 | 4 | |
| 19 | 2009 | 53 | |
| 20 | 2001 | 3 |
About Erik Škof
Erik Škof is a scholar working on Reproductive Medicine, Oncology, Genetics, Obstetrics and Gynecology and Cancer Research, having authored 34 papers that have together received 347 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (15 papers), BRCA gene mutations in cancer (11 papers), PARP inhibition in cancer therapy (8 papers), Cancer Immunotherapy and Biomarkers (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Cells and Metastasis (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Reproductive Medicine (115 citations), Oncology (173 citations), Obstetrics and Gynecology (30 citations), Hepatology (28 citations) and Cancer Research (44 citations). Erik Škof has collaborated with scholars based in Slovenia, Italy and Sweden. Frequent co-authors include Martina Reberšek, Janja Ocvirk, Špela Smrkolj, Vladimir Smrkolj, Borut Kobal, Žiga Snoj, Igor Kocijančič, Leon Meglič, Branko Cvjetičanin and Vida Stegel. Their work appears in journals such as Cancers, Gynecologic Oncology, Journal of Clinical Oncology, BMC Cancer and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.